Quick Answer
Arcus Biosciences, Inc. reported Total Assets of $1.14 billion for fiscal year 2025.
Arcus Biosciences, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.14B | -1.0% |
| 2024 | $1.15B | +5.0% |
| 2023 | $1.09B | -18.6% |
| 2022 | $1.34B | -15.5% |
| 2021 | $1.59B | +106.1% |
| 2020 | $772.29M | +280.2% |
| 2019 | $203.11M | -26.1% |
| 2018 | $274.93M | +44.3% |
| 2017 | $190.49M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $974.00M | -22.2% | -9.4% |
| June 30, 2025 | $1.07B | -9.4% | -7.0% |
| March 31, 2025 | $1.16B | -10.6% | +0.5% |
| December 31, 2024 | $1.15B | +5.0% | -8.1% |
| September 30, 2024 | $1.25B | +5.1% | +5.6% |
| June 30, 2024 | $1.19B | -2.8% | -8.3% |
| March 31, 2024 | $1.29B | +3.1% | +18.1% |
| December 31, 2023 | $1.09B | -18.6% | -8.1% |
- Arcus Biosciences, Inc. showed a decrease of -1.0% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, Arcus Biosciences, Inc.’s total assets has grown by 497.9% (from $190.49 million to $1.14 billion).
- The most recent figure is from Arcus Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: